Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation

Transplantation

Volumn 86, Issue 7, 2008, Pages 919-924

  Borchhardt, Kyra A ^a   Heinzl, Harald ^a   Mayerwöger, Elisabeth ^a   Hörl, Walter H ^a   Haas, Martin ^a   Sunder Plassmann, Gere ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cinacalcet; Hypercalcemia; Hyperparathyroidism; Kidney transplantation; Urinary calcium excretion

Indexed keywords

CALCIUM; CINACALCET; IMMUNOSUPPRESSIVE AGENT; NAPHTHALENE DERIVATIVE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL TOXICITY; HEARING IMPAIRMENT; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; MENTAL HEALTH; PRIORITY JOURNAL; SIDE EFFECT; BLOOD; CHRONIC KIDNEY FAILURE; CLASSIFICATION; GLOMERULUS FILTRATION RATE; IMMUNOLOGY; KIDNEY DISEASE; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; URINE;

ADULT; AGED; CALCIUM; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NAPHTHALENES; POSTOPERATIVE COMPLICATIONS;

EID: 56049091757     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318186b7fb     Document Type: Article

References (38)

1. D'Alessandro AM, Melzer JS, Pirsch JD, et al. Tertiary hyperparathyroidism after renal transplantation: Operative indications. Surgery 1989; 106: 1049.
2. Evenepoel P, Kuypers D, Maes B, et al. Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy. Acta Oto-rhinolaryngol Belg 2001; 55: 177.
3. Kunzendorf U, Kramer BK, Arns W, et al. Bone disease after renal transplantation. Nephrol Dial Transplant 2008; 23: 450.
4. Schlosser K, Zielke A, Rothmund M. Medical and surgical treatment for secondary and tertiary hyperparathyroidism. Scand J Surg 2004; 93: 288.
5. Borchhardt K, Sulzbacher I, Benesch T, et al. Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Transplant 2007; 7: 2515.
6. Gwinner W, Suppa S, Mengel M, et al. Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications. Am J Transplant 2005; 5: 1934.
7. Schlosser K, Endres N, Celik I, et al. Surgical treatment of tertiary hyperparathyroidism: The choice of procedure matters! World J Surg 2007; 31: 1947.
8. Oschatz E, Benesch T, Kodras K, et al. Changes of coronary calcification after kidney transplantation. Am J Kidney Dis 2006; 48: 307.
9. Kruse AE, Eisenberger U, Frey FJ, et al. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1311.
10. Leca N, Laftavi M, Gundroo A, et al. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am J Transplant 2006; 6: 2391.
11. Serra AL, Schwarz AA, Wick FH, et al. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1315.
12. Srinivas TR, Schold JD, Womer KL, et al. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol 2006; 1: 323.
13. Szwarc I, Argiles A, Garrigue V, et al. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 2006; 82: 675.
14. El-Amm JM, Doshi MD, Singh A, et al. Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation 2007; 83: 546.
15. Kruse AE, Eisenberger U, Frey FJ, et al. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2007; 22: 2362.
16. Henley C, Colloton M, Cattley RC, et al. 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1370.
17. Serra AL, Savoca R, Huber AR, et al. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 2007; 22: 577.
18. Levey AS. Clinical practice. Nondiabetic kidney disease. N Engl J Med 2002; 347: 1505.
19. Huang C, Miller RT. Regulation of renal ion transport by the calcium-sensing receptor: An update. Curr Opin Nephrol Hypertens 2007; 16: 437.
20. Drüeke TB. Modulation and action of the calcium-sensing receptor. Nephrol Dial Transplant 2004; 19(suppl 5): V20.
21. Imura A, Tsuji Y, Murata M, et al. alpha-Klotho as a regulator of calcium homeostasis. Science 2007; 316: 1615.
22. D'Souza-Li L. The calcium-sensing receptor and related diseases. Arq Bras Endocrinol Metabol 2006; 50: 628.
23. Brown EM, Hebert SC. Calcium-receptor-regulated parathyroid and renal function. Bone 1997; 20: 303.
24. Friedman PA. Renal calcium metabolism. In: Seldin DW, Giebisch G, eds. The kidney, physiology and pathophysiology. Philadelphia, Lippi-cott Williams and Wilkins 2000, p 1749.
25. Hoenderop JG, Nilius B, Bindels RJ. Molecular mechanism of active Ca2+ reabsorption in the distal nephron. Annu Rev Physiol 2002; 64: 529.
26. van Abel M, Hoenderop JG, van der Kemp AW, et al. Coordinated control of renal Ca(2 + ) transport proteins by parathyroid hormone. Kidney Int 2005; 68: 1708.
27. Kos CH, Karaplis AC, Peng JB, et al. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest 2003; 111: 1021.
28. Ritz E. Calcimimetics - Fooling the calcium receptor. Pediatr Nephrol 2005; 20: 15.
29. Antonsen JE, Sherrard DJ, Andress DL. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication. Kidney Int 1998; 53: 223.
30. Serra AL, Braun SC, Starke A, et al. Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation. Am J Transplant 2008; 8: 803.
31. Shoback DM, Bilezikian JP, Turner SA, et al. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 2003; 88: 5644.
32. Peacock M, Bilezikian JP, Klassen PS, et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyper-parathyroidism. J Clin Endocrinol Metab 2005; 90: 135.
33. Schwarz C, Benesch T, Kodras K, et al. Complete renal tubular acidosis late after kidney transplantation. Nephrol Dial Transplant 2006; 21: 2615.
34. Parfitt AM. Misconceptions I. V-the hypophosphatemia of primary hyperparathyroidism is the result of renal phosphate wasting. Bone 2004; 35: 345.
35. Traebert M, Roth J, Biber J, et al. Internalization of proximal tubular type II Na-P (i) cotransporter by PTH: Immunogold electron microscopy. Am J Physiol Renal Physiol 2000; 278: F148.
36. Peng LW, Logan JL, James SH, et al. Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient. Am J Med 2007; 120: e7.
37. Morton CC, Nance WE. Newborn hearing screening - A silent revolution. N Engl J Med 2006; 354: 2151.
38. Moe SM. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Invest 2006; 36(suppl 2): 51.